^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Oncomine™ TCR Pan-Clonality Assay

    Company:
    Thermo Fisher Scientific
    Type:
    Laboratory Developed Test
    Related tests:
    Details
    Evidence

    News

    1year
    Adoptively Infused Memory-like Natural Killer Cells Impact Adaptive Immune Responses in Patients with Acute Myeloid Leukemia (ASH 2023)
    Patients were lymphodepleted with fludarabine and cyclophosphamide...Multi-modal analyses of WU-NK-101 highlight unique transcriptional and functional states, which could underpin in vivo potency and persistence. WU-NK-101 are currently being evaluated in a phase 1 study of R/R AML (#NCT05470140).
    Clinical • PARP Biomarker • IO biomarker
    |
    CD8 (cluster of differentiation 8) • LAG3 (Lymphocyte Activating 3) • CD276 (CD276 Molecule) • HAVCR2 (Hepatitis A Virus Cellular Receptor 2) • CD34 (CD34 molecule) • PARP1 (Poly(ADP-Ribose) Polymerase 1) • NCAM1 (Neural cell adhesion molecule 1) • STING (stimulator of interferon response cGAMP interactor 1) • IL18 (Interleukin 18) • CD7 (CD7 Molecule) • IL15 (Interleukin 15) • TRB (T Cell Receptor Beta Locus)
    |
    nCounter® PanCancer IO 360™ Panel • Oncomine™ TCR Pan-Clonality Assay
    |
    cyclophosphamide • fludarabine IV • WU-NK-101